---
figid: PMC7868022__12935_2021_1793_Fig3_HTML
figlink: pmc/articles/PMC7868022/figure/Fig3/
number: F3
caption: EBV-induced oncogenesis through the JAK/STAT signaling pathway. When JAK
  is activated, it can phosphorylate STAT, and then dimeric STAT is exposed to the
  nuclear signal and enters the nucleus to participate in regulating gene expression.
  LMP1 can activate JAKs and then activate the STAT dimer, which promotes the corresponding
  transcriptional regulation in the nucleus and can provide feedback and enhance the
  regulation of its own expression. LMP1 enhances the transcription of AP-1 through
  JAK/STAT and promotes the expression of PD-L1 to avoid immune surveillance. LMP1
  and LMP2A can activate HLX to inhibit apoptosis
pmcid: PMC7868022
papertitle: Signaling pathways of EBV-induced oncogenesis.
reftext: Yin Luo, et al. Cancer Cell Int. 2021;21:93.
pmc_ranked_result_index: '34351'
pathway_score: 0.9620589
filename: 12935_2021_1793_Fig3_HTML.jpg
figtitle: EBV-induced oncogenesis through the JAK/STAT signaling pathway
year: '2021'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7868022__12935_2021_1793_Fig3_HTML.html
  '@type': Dataset
  description: EBV-induced oncogenesis through the JAK/STAT signaling pathway. When
    JAK is activated, it can phosphorylate STAT, and then dimeric STAT is exposed
    to the nuclear signal and enters the nucleus to participate in regulating gene
    expression. LMP1 can activate JAKs and then activate the STAT dimer, which promotes
    the corresponding transcriptional regulation in the nucleus and can provide feedback
    and enhance the regulation of its own expression. LMP1 enhances the transcription
    of AP-1 through JAK/STAT and promotes the expression of PD-L1 to avoid immune
    surveillance. LMP1 and LMP2A can activate HLX to inhibit apoptosis
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - JAK3
  - STAT3
  - STAT5A
  - STAT5B
  - FOS
  - FOSB
  - FOSL2
  - JUN
  - JUNB
  - FOSL1
  - JUND
  - HLX
  - CD274
  - SPIB
  - NKX6-3
  - BCL2L11
  - IL4R
genes:
- word: JAK3
  symbol: JAK3
  source: hgnc_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK3
  symbol: JAK3
  source: hgnc_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT5
  symbol: STAT5
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT5
  symbol: STAT5
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: АP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: АP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: АP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: АP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: АP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: АP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: АP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: HLX
  symbol: HLX
  source: hgnc_symbol
  hgnc_symbol: HLX
  entrez: '3142'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: SPIB
  symbol: SPIB
  source: hgnc_symbol
  hgnc_symbol: SPIB
  entrez: '6689'
- word: NKX6-3
  symbol: NKX6-3
  source: hgnc_symbol
  hgnc_symbol: NKX6-3
  entrez: '157848'
- word: BCL2L11
  symbol: BCL2L11
  source: hgnc_symbol
  hgnc_symbol: BCL2L11
  entrez: '10018'
- word: IL4R
  symbol: IL4R
  source: hgnc_symbol
  hgnc_symbol: IL4R
  entrez: '3566'
chemicals: []
diseases: []
figid_alias: PMC7868022__F3
redirect_from: /figures/PMC7868022__F3
figtype: Figure
---
